Danggui Buxue Tang Inhibits 2,4-Dinitrochlorobenzene: Induced Atopic Dermatitis in Mice

Figure 1

A summary of the development of AD-like skin lesions in DNCB-treated mice. The dorsal skin of mice was shaved and treated with topical 0.5% DNCB on days 1–3. Next, the mice were challenged with 1% DNCB on days 14, 17, 20, 23, 26, and 29. AD-like mice were treated with topical Danggui Buxue Tang (DBT) on days 14–27. Finally, mice were sacrificed on day 30.